Wedbush Securities’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,269
Closed -$221K 1036
2020
Q3
$221K Sell
2,269
-530
-19% -$61K 0.02% 736
2020
Q2
$343K Sell
2,799
-70
-2% -$7.94K 0.03% 561
2020
Q1
$251K Buy
2,869
+459
+19% +$48.6K 0.03% 593
2019
Q4
$252K Buy
+2,410
New +$270K 0.02% 745
2019
Q3
Sell
-1,178
Closed -$203K 1043
2019
Q2
$203K Sell
1,178
-300
-20% -$51.9K 0.02% 817
2019
Q1
$249K Buy
+1,478
New +$220K 0.03% 673

Other funds holding GWPH

Wedbush Securities's GWPH Position: Q4 2020 in Review

Wedbush Securities sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 2,269 shares — an estimated $221K sold.

Wedbush Securities first reported a position in GWPH in Q1 2019 and held it in 6 quarters. The position peaked at $343K in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Wedbush Securities reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 2,269 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $221K.
  • Wedbush Securities first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 6 quarters.
  • Wedbush Securities's GW Pharmaceuticals Plc American Depositary Shares position peaked at $343K in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.